Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
congestive heart failure
Pharma
Esperion pays $75M for Corstasis and FDA-approved nasal spray
Esperion has paid $75 million upfront to acquire Corstasis Therapeutics and its nasal spray Enbumyst, which was approved by the FDA six months ago.
Kevin Dunleavy
Mar 3, 2026 8:40am
FDA approves Corstasis' nasal spray as treatment for edema
Sep 15, 2025 3:33pm
FDA signs off on scPharmaceutical’s on-body infusor for HF
Oct 10, 2022 10:51am
Teva is eyeing a new venue for its 'skinny' labels feud with GSK
Feb 17, 2022 9:35am
Lilly's Trulicity joins pay-for-performance trend with Harvard Pilgrim deal
Jun 28, 2016 10:44am
